Equillium EQ
NASDAQ EQ
$2.21 -0.01 (-0.45%)
At close: Sep 4, 2026 · 4:00 PM EDT

Equillium (EQ) Other Accumulated Expenses (2017 - 2026)

Equillium (EQ) posted quarterly Other Accumulated Expenses of $418000.0 for Q1 2026, down 35.59% year-over-year from $649000.0 in Q1 2025, and up 96.24% quarter-over-quarter from $213000.0 in Q4 2025.

Analysis

Equillium (EQ) Other Accumulated Expenses (2017 - 2026) Analysis & Trends

Equillium (EQ) has reported Other Accumulated Expenses for 10 consecutive years, with $418000.0 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Other Accumulated Expenses fell 35.59% year-over-year to $418000.0; the TTM figure through Mar 2026 stood at $418000.0 (down 35.59% YoY), while the FY2025 annual figure was $213000.0, down 29.7% from the prior year.
  • Other Accumulated Expenses rose to $418000.0 in Q1 2026 per EQ's latest filing, from $213000.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $749000.0 in Q3 2022 and bottomed at $129000.0 in Q2 2025.
  • Historically, Other Accumulated Expenses has averaged $440647.1 across 5 years, with a median of $431000.0 in 2023.
  • Annual changes were most pronounced in 2022 — Other Accumulated Expenses jumped 345.83% — and 2025, when it plunged 67.75%.
  • Equillium's Other Accumulated Expenses stood at $472000.0 in 2022, then retreated by 8.69% to $431000.0 in 2023, then dropped by 29.7% to $303000.0 in 2024, then fell by 29.7% to $213000.0 in 2025, then jumped by 96.24% to $418000.0 in 2026.
  • Business Quant data shows EQ's Other Accumulated Expenses at $418000.0 in Q1 2026, $213000.0 in Q4 2025, and $253000.0 in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Equillium 249.33 Mn 249.33 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 162,000.00
Mar 31, 2026 418,000.00
Dec 31, 2025 213,000.00
Sep 30, 2025 253,000.00
Jun 30, 2025 129,000.00
Mar 31, 2025 649,000.00
Dec 31, 2024 303,000.00
Sep 30, 2024 443,000.00
Jun 30, 2024 400,000.00
Mar 31, 2024 483,000.00
Dec 31, 2023 431,000.00
Sep 30, 2023 595,000.00
Jun 30, 2023 661,000.00
Mar 31, 2023 732,000.00
Dec 31, 2022 472,000.00
Sep 30, 2022 749,000.00
Jun 30, 2022 252,000.00
Mar 31, 2022 308,000.00
Dec 31, 2021 245,000.00
Sep 30, 2021 168,000.00